Article
Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.
Journal of cellular physiology - 1 Nov 1990
Cutts J L, Bankhurst A D
Abstract excerpt
The activation of human natural killer (NK) cell cytotoxicity by interleukin 2 (IL-2) is well established, although the biochemical mechanisms of this stimulation have not yet been fully delineated. Earlier, we reported that treatment of NK cells with an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase such as compactin or lovastatin significantly abrogates the in vitro killing of a...
Topics
- Acetates
- Antibody-Dependent Cell Cytotoxicity
- Chemotaxis, Leukocyte
- Cholesterol
- Cytotoxicity, Immunologic
- DNA Replication
- Humans
- In Vitro Techniques
- Interleukin-2
- Killer Cells, Natural
- Lovastatin
